Rheumatology
Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis
Barbara Ruaro, Vanessa Smith, Alberto Sulli, Saskia Decuman, Carmen Pizzorni, Maurizio Cutolo
Korean J Intern Med. 2015;30(1):1-5. Published online December 30, 2014
Systemic sclerosis is a connective tissue disease characterized by alterations in microvascular structure and function. In these patients, numerous studies have demonstrated a relationship between capillary morphology and peripheral blood perfusion. Nailfold videocapillaroscopy reveals the periphera..
|
|
Type B insulin-resistance syndrome presenting as autoimmune hypoglycemia, associated with systemic lupus erythematosus and interstitial lung disease
Seon Mee Kang, Heung Yong Jin, Kyung Ae Lee, Ji Hyun Park, Hong Sun Baek, Tae Sun Park
Korean J Intern Med. 2013;28(1):98-102. Published online December 28, 2012
We describe an unusual case of systemic lupus erythematosus with pulmonary manifestations presenting as hypoglycemia due to anti-insulin receptor antibodies. A 38-year-old female suffered an episode of unconsciousness and was admitted to hospital where her blood glucose was found to be 18 mg/dL. ..
|
|
Intracranial Vasculopathy in a Patient with Systemic Sclerosis: Atherosclerotic or Moyamoya-Like Disease?
Han Na Choi, Si Hye Kim, Hyun Hee Kim, Seong-Kyu Kim, Jung-Yoon Choe, Sung-Hoon Park
Korean J Intern Med. 2012;27(2):239-242. Published online May 31, 2012
|
|
A Case of Minimal Change Disease Treated Successfully with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus
Young Hoon Hong, Dae Young Yun, Yong Wook Jung, Myung Jin Oh, Hyun Je Kim, Choong Ki Lee
Korean J Intern Med. 2011;26(4):470-473. Published online November 28, 2011
The World Health Organization classifies lupus nephritis as class I to V or VI. However, a few cases of minimal change glomerulopathy have been reported in association with systemic lupus erythematosus (SLE). Mycophenolate mofetil has been shown to be effective for treatment of minimal change dis..
|
|
Comparison of Clinical Outcomes by Different Renal Replacement Therapy in Patients with End-Stage Renal Disease Secondary to Lupus Nephritis
Seok-Hui Kang, Byung-Ha Chung, Sun-Ryoung Choi, Ja-Young Lee, Hoon-Suk Park, In-O Sun, Bum-Soon Choi, Cheol-Whee Park, Yong-Soo Kim, Chul-Woo Yang
Korean J Intern Med. 2011;26(1):60-67. Published online March 2, 2011
Background/AimsMany studies have compared patients with systemic lupus erythematosus (SLE) on renal replacement therapy (RRT) with non-lupus patients. However, few data are available on the long-term outcome of patients with end-stage renal disease (ESRD) secondary to SLE who ..
|
|
A Case of Spontaneous Hemoperitoneum Presenting as the Initial Manifestation of Systemic Lupus Erythematosus
Sang-Seokg Seong, Chung-Il Joung
Korean J Intern Med. 2010;25(4):458-460. Published online November 27, 2010
Thrombocytopenia is included in the classification criteria for systemic lupus erythematosus (SLE). However, severe thrombocytopenia causing spontaneous bleeding is rare. Here, we describe a 22-year-old woman who presented with spontaneous hemoperitoneum as the first manifestation of SLE. Laborat..
|
|
A Case of Systemic Lupus Erythematosus Presenting as Malignant Hypertension with Hypertensive Retinopathy
Jung-Yoon Choe, Sung-Hoon Park, Ji-Young Kim, Hyun-Young Jung, Seong-Kyu Kim
Korean J Intern Med. 2010;25(3):341-344. Published online August 31, 2010
The variability of cardiovascular abnormalities is one of the characteristics of systemic lupus erythematosus (SLE). Among the cardiovascular manifestations, hypertension is reported in 14% to 58.1% of patients in diverse ethnic populations, and remains a clinically important issue due to its clo..
|
|
A New Onset of Systemic Lupus Erythematosus Developed After Bee Venom Therapy
Young Hee Rho, Jin-Hyun Woo, Seong Jae Choi, Young Ho Lee, Jong Dae Ji, Gwan Gyu Song
Korean J Intern Med. 2009;24(3):283-285. Published online August 26, 2009
Lupus is a systemic autoimmune disease of an unknown origin, and systemic lupus erythematosus (SLE) can be triggered by numerous stimuli. Bee venom therapy is an alternative therapy that is believed to be effective for various kinds of arthritis. We present here a case of a 49-year-old female who..
|
|
An Antinuclear Antibody-Negative Patient With Lupus Nephritis
Hyoun-Ah Kim, Jae-Wook Chung, Han-Jung Park, Dai-Yeol Joe, Hyun-Ee Yim, Hae-Sim Park, Chang-Hee Suh
Korean J Intern Med. 2009;24(1):76-79. Published online March 6, 2009
Systemic lupus erythematosus (SLE) is a typical autoimmune disease that's characterized by various autoantibodies to nuclear and cytoplasmic antigens. The presence of antinuclear antibodies (ANA) in serum is generally considered a decisive diagnostic sign of SLE. However, a small subset of SLE pa..
|
|
Two Cases of Systemic Capillary Leak Syndrome that were Treated with Pentastarch
Young Seok Lee, Sun Young Kim, Chin Woo Kwon, Hae Geun Song, Young Kyung Lee, Hyo Jung Kim, Dae Young Zang
Korean J Intern Med. 2007;22(2):130-132. Published online June 30, 2007
Systemic capillary leak syndrome (SCLS) is a condition that's caused by the shift of fluid and protein from the intravascular space to the interstitial space as a result of repetitive episodes of capillary hyperpermeability. The pathogenesis of SCLS is still unclear, but there's recently been a r..
|
|
Comparison of the Clinical Manifestations, Brain MRI and Prognosis between NeuroBehçet's Disease and Neuropsychiatric Lupus
Byung-Sik Cho, Hyun-Sook Kim, Su-Jin Oh, Hyeok-Jae Ko, Chong-Hyun Yoon, So-Lyung Jung, Do-June Min, Wan-Uk Kim
Korean J Intern Med. 2007;22(2):77-86. Published online June 30, 2007
BackgroundNeuropsychiatric systemic lupus erythematosus (NPSLE) shows some similarities to neuroBehçet's disease (NBD) in that both conditions have some analogous clinical features and they are both pathologically associated cerebral vasculopathy. This study compared the cli..
|
|
|